Skip to main content
. 2016 Jun;5(3):263–269. doi: 10.21037/gs.2015.12.03

Table 1. Demographic, clinical and perioperative data of study patients (n=206).

Parameter N
Age 62.1±11.2
Gender (F/M) 85/121
ASA status 2.7±0.5
Primary tumor (colon/rectum) 129/77
Type of metastasis (synchronous/metachronous) 79/127
Liver involvement (unilobar/bilobar) 178/28
Number of liver metastases 1.7±1.1
Tumor size (cm) 3.8±2.3
Preoperative CEA level (ng/mL) 80.6±321.1
Type of resection (minor/major) 133/73
Estimated blood loss (mL) 604±709
Blood transfusion, n (%) 29 (14%)
Operative time (min) 261±103
Margin status (R0/R1) 157/49
Complications 60 (29%)
ICU stay 62 (30%)
Hospital stay (day) 6.5±4.0

Continuous data are presented as mean ± standard error of the mean. F, female; M, male; ASA, American Society of Anesthesiologist score; CEA, carcinoembryonic antigen; ICU, intensive care unit.